234 related articles for article (PubMed ID: 11746262)
1. Plasma membrane association of cathepsin B in human prostate cancer: biochemical and immunogold electron microscopic analysis.
Sinha AA; Jamuar MP; Wilson MJ; Rozhin J; Sloane BF
Prostate; 2001 Nov; 49(3):172-84. PubMed ID: 11746262
[TBL] [Abstract][Full Text] [Related]
2. Ratio of cathepsin B to stefin A identifies heterogeneity within Gleason histologic scores for human prostate cancer.
Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Sloane BF; Gleason DF
Prostate; 2001 Sep; 48(4):274-84. PubMed ID: 11536307
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis.
Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF
Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734
[TBL] [Abstract][Full Text] [Related]
4. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF
Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560
[TBL] [Abstract][Full Text] [Related]
5. Codistribution of procathepsin B and mature cathepsin B forms in human prostate tumors detected by confocal and immunofluorescence microscopy.
Sinha AA; Quast BJ; Wilson MJ; Reddy PK; Gleason DF; Sloane BF
Anat Rec; 1998 Oct; 252(2):281-9. PubMed ID: 9776083
[TBL] [Abstract][Full Text] [Related]
6. Localization of cathepsin B in normal and hyperplastic human prostate by immunoperoxidase and protein A-gold techniques.
Sinha AA; Gleason DF; Limas C; Reddy PK; Wick MR; Hagen KA; Wilson MJ
Anat Rec; 1989 Mar; 223(3):266-75. PubMed ID: 2646985
[TBL] [Abstract][Full Text] [Related]
7. Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization.
Sinha AA; Gleason DF; Deleon OF; Wilson MJ; Sloane BF
Anat Rec; 1993 Feb; 235(2):233-40. PubMed ID: 7678371
[TBL] [Abstract][Full Text] [Related]
8. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue.
Friedrich B; Jung K; Lein M; Türk I; Rudolph B; Hampel G; Schnorr D; Loening SA
Eur J Cancer; 1999 Jan; 35(1):138-44. PubMed ID: 10211102
[TBL] [Abstract][Full Text] [Related]
9. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
[TBL] [Abstract][Full Text] [Related]
10. Redistribution of cathepsin B activity from the endosomal-lysosomal pathway in chick intestine within 3 min of calcium absorption.
Nemere I; Norman AW
Mol Cell Endocrinol; 1991 Jun; 78(1-2):7-16. PubMed ID: 1936526
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of prostate specific antigen (PSA) in benign and malignant tumors of the prostate.
Dema A; Tudose N
Rom J Morphol Embryol; 1998; 44(1-4):93-100. PubMed ID: 15678849
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
14. Distribution and subcellular localization of a lysosome-associated protein in human genital organs.
Aumüller G; Renneberg H; Hasilik A
Cell Tissue Res; 1997 Feb; 287(2):335-42. PubMed ID: 8995204
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin B expression is similar in African-American and Caucasian prostate cancer patients.
Sinha AA; Morgan JL; Buus RJ; Ewing SL; Fernandes ET; Le C; Wilson MJ
Anticancer Res; 2007; 27(5A):3135-41. PubMed ID: 17970054
[TBL] [Abstract][Full Text] [Related]
16. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
[TBL] [Abstract][Full Text] [Related]
17. Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia.
Björk T; Bjartell A; Abrahamsson PA; Hulkko S; di Sant'Agnese A; Lilja H
Urology; 1994 Apr; 43(4):427-34. PubMed ID: 7512295
[TBL] [Abstract][Full Text] [Related]
18. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene.
Sloane BF; Moin K; Sameni M; Tait LR; Rozhin J; Ziegler G
J Cell Sci; 1994 Feb; 107 ( Pt 2)():373-84. PubMed ID: 8207069
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of cathepsin B in neoplastic human prostate.
Sinha AA; Wilson MJ; Gleason DF; Reddy PK; Sameni M; Sloane BF
Prostate; 1995 Apr; 26(4):171-8. PubMed ID: 7716081
[TBL] [Abstract][Full Text] [Related]
20. Expression of acid cysteine proteinase inhibitor (ACPI) in the normal human prostate, benign prostatic hyperplasia and adenocarcinoma.
Söderström KO; Laato M; Wu P; Hopsu-Havu VK; Nurmi M; Rinne A
Int J Cancer; 1995 Jul; 62(1):1-4. PubMed ID: 7541394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
